XML 14 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' (Deficit) Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 414 $ 417,315 $ (414,502) $ 3,227
Beginning balance, shares at Dec. 31, 2019 115 413,701,289      
Common stock issued on conversion of notes payable $ 33 317 350
Common stock issued on conversion of notes payable, shares   32,747,157      
Stock based compensation - employee restricted stock 220 220
Net Loss (1,324) (1,324)
Ending balance, value at Mar. 31, 2020 $ 447 417,852 (415,826) 2,473
Ending balance, shares at Mar. 31, 2020 115 446,448,446      
Beginning balance, value at Dec. 31, 2019 $ 414 417,315 (414,502) 3,227
Beginning balance, shares at Dec. 31, 2019 115 413,701,289      
Net Loss         (3,332)
Ending balance, value at Sep. 30, 2020 $ 507 418,374 (417,834) 1,047
Ending balance, shares at Sep. 30, 2020 115 506,779,781      
Beginning balance, value at Dec. 31, 2019 $ 414 417,315 (414,502) 3,227
Beginning balance, shares at Dec. 31, 2019 115 413,701,289      
Ending balance, value at Dec. 31, 2020 $ 507 418,373 (418,389) 491
Ending balance, shares at Dec. 31, 2020 115 506,779,781      
Beginning balance, value at Mar. 31, 2020 $ 447 417,852 (415,826) 2,473
Beginning balance, shares at Mar. 31, 2020 115 446,448,446      
Common stock issued on conversion of notes payable $ 43 382 425
Common stock issued on conversion of notes payable, shares   43,166,603      
Stock based compensation - employee restricted stock 2 2
Net Loss   (1,416) (1,416)
Ending balance, value at Jun. 30, 2020 $ 490 418,236 (417,242) 1,484
Ending balance, shares at Jun. 30, 2020 115 489,615,049      
Common stock issued on conversion of notes payable $ 17 137 154
Common stock issued on conversion of notes payable, shares   17,164,732      
Stock based compensation - employee restricted stock 1 1
Net Loss   (592) (592)
Ending balance, value at Sep. 30, 2020 $ 507 418,374 (417,834) 1,047
Ending balance, shares at Sep. 30, 2020 115 506,779,781      
Beginning balance, value at Dec. 31, 2020 $ 507 418,373 (418,389) 491
Beginning balance, shares at Dec. 31, 2020 115 506,779,781      
Stock based compensation - employee restricted stock  
Common stock issued on conversion of Preferred C shares $ 30 (30)
Common stock issued on conversion of Preferred C shares, shares (115) 29,870,130      
Beneficial conversion feature     1,000   1,000
Net Loss (581) (581)
Ending balance, value at Mar. 31, 2021 $ 537 419,343 (418,970) 910
Ending balance, shares at Mar. 31, 2021 536,649,911      
Beginning balance, value at Dec. 31, 2020 $ 507 418,373 (418,389) 491
Beginning balance, shares at Dec. 31, 2020 115 506,779,781      
Net Loss         (1,620)
Ending balance, value at Sep. 30, 2021 $ 583 419,839 (420,009) 413
Ending balance, shares at Sep. 30, 2021 583,470,903      
Beginning balance, value at Mar. 31, 2021 $ 537 419,343 (418,970) 910
Beginning balance, shares at Mar. 31, 2021 536,649,911      
Common stock issued on conversion of notes payable $ 4 233 237
Common stock issued on conversion of notes payable, shares   4,761,905      
Net Loss   (665) (665)
Ending balance, value at Jun. 30, 2021 $ 541 419,576 (419,635) 482
Ending balance, shares at Jun. 30, 2021 541,411,816      
Issuance of common stock and warrants $ 35 (10) 25
Issuance of common stock and warrants, shares   35,385,703      
Common stock issued on conversion of notes payable $ 7 273 280
Common stock issued on conversion of notes payable, shares   6,673,384      
Net Loss       (374) (374)
Ending balance, value at Sep. 30, 2021 $ 583 $ 419,839 $ (420,009) $ 413
Ending balance, shares at Sep. 30, 2021 583,470,903